| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comparative evaluation of treatment methods for bile duct stones after hepaticojejunostomy between percutaneous transhepatic cholangioscopy and peroral, short double-balloon enteroscopy
|
Tsutsumi, Koichiro
|
|
2017
|
|
1 |
p. 54-67
|
artikel
|
| 2 |
Acquired factor VII deficiency following FOLFOX in a patient with colorectal cancer who was also DPD deficient
|
Saif, Muhammad Wasif
|
|
2016
|
|
1 |
p. 121-127
|
artikel
|
| 3 |
A gastrointestinal anti-infectious biotherapeutic agent: the heat-treated Lactobacillus LB
|
Liévin-Le Moal, Vanessa
|
|
2016
|
|
1 |
p. 57-75
|
artikel
|
| 4 |
Antispasmodic drugs in colonoscopy: a review of their pharmacology, safety and efficacy in improving polyp detection and related outcomes
|
Sanagapalli, Santosh
|
|
2017
|
|
1 |
p. 101-113
|
artikel
|
| 5 |
A review of rifaximin and bacterial overgrowth in poorly responsive celiac disease
|
Chang, Matthew S.
|
|
2012
|
|
1 |
p. 31-36
|
artikel
|
| 6 |
Association between caffeine consumption and nonalcoholic fatty liver disease: a systemic review and meta-analysis
|
Shen, Huafeng
|
|
2016
|
|
1 |
p. 113-120
|
artikel
|
| 7 |
Blue laser imaging endoscopy system for the early detection and characterization of colorectal lesions: a guide for the endoscopist
|
Togashi, Kazutomo
|
|
2016
|
|
1 |
p. 50-56
|
artikel
|
| 8 |
Complete circumferential rectal ulceration and haemorrhage secondary to the use of a faecal management system
|
Shaker, Hudhaifah
|
|
2014
|
|
1 |
p. 51-55
|
artikel
|
| 9 |
Covered versus bare stents for transjugular intrahepatic portosystemic shunt: an updated meta-analysis of randomized controlled trials
|
Qi, Xingshun
|
|
2017
|
|
1 |
p. 32-41
|
artikel
|
| 10 |
Degree of concordance between single balloon enteroscopy and capsule endoscopy for obscure gastrointestinal bleeding after an initial positive capsule endoscopy finding
|
Shiani, Ashok
|
|
2016
|
|
1 |
p. 13-18
|
artikel
|
| 11 |
Editorial
|
Wang, Timothy Cragin
|
|
2008
|
|
1 |
p. 5-6
|
artikel
|
| 12 |
Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation
|
Hemarajata, Peera
|
|
2013
|
|
1 |
p. 39-51
|
artikel
|
| 13 |
EUS-guided cholecystoduodenostomy for acute cholecystitis with an anti-stent migration and anti-food impaction system; a pilot study
|
Takagi, Wataru
|
|
2016
|
|
1 |
p. 19-25
|
artikel
|
| 14 |
Everolimus in the management of metastatic neuroendocrine tumours
|
Chan, David L.
|
|
2017
|
|
1 |
p. 132-141
|
artikel
|
| 15 |
Gastrointestinal manifestations of mitochondrial disorders: a systematic review
|
Finsterer, Josef
|
|
2017
|
|
1 |
p. 142-154
|
artikel
|
| 16 |
Golimumab pharmacokinetics in ulcerative colitis: a literature review
|
Harzallah, Ines
|
|
2017
|
|
1 |
p. 89-100
|
artikel
|
| 17 |
Grazoprevir/elbasvir combination therapy for HCV infection
|
Vallet-Pichard, Anaïs
|
|
2017
|
|
1 |
p. 155-167
|
artikel
|
| 18 |
Immunotherapy in pancreatic cancer treatment: a new frontier
|
Thind, Komal
|
|
2017
|
|
1 |
p. 168-194
|
artikel
|
| 19 |
Lactobacillus reuteri in management of Helicobacter pylori infection in dyspeptic patients: a double-blind placebo-controlled randomized clinical trial
|
Emara, Mohamed H.
|
|
2014
|
|
1 |
p. 4-13
|
artikel
|
| 20 |
Low vitamin D level is an independent predictor of poor outcomes in Clostridium difficile-associated diarrhea
|
Wang, Wallace J.
|
|
2014
|
|
1 |
p. 14-19
|
artikel
|
| 21 |
Management of patients with faecal incontinence
|
Duelund-Jakobsen, Jakob
|
|
2016
|
|
1 |
p. 86-97
|
artikel
|
| 22 |
Molecular targeted therapies in advanced gastric cancer: does tumor histology matter?
|
Wong, Hilda
|
|
2013
|
|
1 |
p. 15-31
|
artikel
|
| 23 |
Nausea: a review of pathophysiology and therapeutics
|
Singh, Prashant
|
|
2016
|
|
1 |
p. 98-112
|
artikel
|
| 24 |
New insights and challenges in microscopic colitis
|
Ohlsson, Bodil
|
|
2015
|
|
1 |
p. 37-47
|
artikel
|
| 25 |
Obesity management: what brings success?
|
Lagerros, Ylva Trolle
|
|
2013
|
|
1 |
p. 77-88
|
artikel
|
| 26 |
Optimal biliary access point and learning curve for endoscopic ultrasound-guided hepaticogastrostomy with transmural stenting
|
Oh, Dongwook
|
|
2017
|
|
1 |
p. 42-53
|
artikel
|
| 27 |
Panitumumab in the management of patients with KRAS wild-type metastatic colorectal cancer
|
Hocking, Christopher M.
|
|
2014
|
|
1 |
p. 20-37
|
artikel
|
| 28 |
Possible interactions between dietary fibres and 5-aminosalicyclic acid
|
Henriksen, Camilla
|
|
2010
|
|
1 |
p. 5-9
|
artikel
|
| 29 |
Practice patterns in NAFLD and NASH: real life differs from published guidelines
|
Rinella, Mary E.
|
|
2016
|
|
1 |
p. 4-12
|
artikel
|
| 30 |
Prevalence of end of treatment RNA-positive/sustained viral response in HCV patients treated with sofosbuvir combination therapies
|
Malespin, Miguel
|
|
2017
|
|
1 |
p. 68-73
|
artikel
|
| 31 |
Prospective study of factors important to achieve observation of the entire colon on colon capsule endoscopy
|
Sato, Junichi
|
|
2017
|
|
1 |
p. 20-31
|
artikel
|
| 32 |
Prucalopride: safety, efficacy and potential applications
|
Quigley, Eamonn M. M.
|
|
2012
|
|
1 |
p. 23-30
|
artikel
|
| 33 |
Radiofrequency ablation for the treatment of radiation proctitis: a case report and review of literature
|
Eddi, Rodney
|
|
2013
|
|
1 |
p. 69-76
|
artikel
|
| 34 |
Review: A clinical guide to using intravenous proton-pump inhibitors in reflux and peptic ulcers
|
Pang, Sandy H.
|
|
2010
|
|
1 |
p. 11-22
|
artikel
|
| 35 |
Review: Chemoprevention of esophageal adenocarcinoma
|
Abrams, Julian A.
|
|
2008
|
|
1 |
p. 7-18
|
artikel
|
| 36 |
Review: Current management strategies and therapeutic targets in chronic constipation
|
Emmanuel, Anton
|
|
2011
|
|
1 |
p. 37-48
|
artikel
|
| 37 |
Review: Current status of antiviral therapy for hepatitis B
|
Lau, Daryl T.-Y.
|
|
2008
|
|
1 |
p. 61-75
|
artikel
|
| 38 |
Review: Efficacy and safety of adalimumab in Crohn's disease
|
Lichtenstein, Gary R.
|
|
2008
|
|
1 |
p. 43-50
|
artikel
|
| 39 |
Review: Enteroendocrine cells: Neglected players in gastrointestinal disorders?
|
Moran, Gordon W.
|
|
2008
|
|
1 |
p. 51-60
|
artikel
|
| 40 |
Review: Hepatitis C virus replication and potential targets for direct-acting agents
|
O'Leary, Jacqueline G.
|
|
2010
|
|
1 |
p. 43-53
|
artikel
|
| 41 |
Review: Hepatocellular carcinoma: review of current treatment with a focus on targeted molecular therapies
|
Olsen, Sonja K.
|
|
2010
|
|
1 |
p. 55-66
|
artikel
|
| 42 |
Review: Immunomodulators for all patients with inflammatory bowel disease?
|
Ardizzone, Sandro
|
|
2010
|
|
1 |
p. 31-42
|
artikel
|
| 43 |
Review: Oral administration of Alequel, a mixture of autologous colon-extracted proteins for the treatment of Crohn’s disease
|
Israeli, Eran
|
|
2010
|
|
1 |
p. 23-30
|
artikel
|
| 44 |
Review: Prevention of gastric cancer: When is treatment of Helicobacter pylori warranted?
|
Peek, Richard M.
|
|
2008
|
|
1 |
p. 19-31
|
artikel
|
| 45 |
Review: Systemic treatment of advanced colorectal cancer: Tailoring therapy to the tumor
|
Carethers, John M.
|
|
2008
|
|
1 |
p. 33-42
|
artikel
|
| 46 |
Review: Treatment of alcoholic liver disease
|
Frazier, Thomas H.
|
|
2011
|
|
1 |
p. 63-81
|
artikel
|
| 47 |
Review: Vitamin D and gastrointestinal diseases: inflammatory bowel disease and colorectal cancer
|
Raman, Maitreyi
|
|
2011
|
|
1 |
p. 49-62
|
artikel
|
| 48 |
Routine screening for eosinophilic esophagitis in patients presenting with dysphagia
|
Ricker, Jonathan
|
|
2011
|
|
1 |
p. 27-35
|
artikel
|
| 49 |
Screening for celiac disease in average-risk and high-risk populations
|
Aggarwal, Saurabh
|
|
2012
|
|
1 |
p. 37-47
|
artikel
|
| 50 |
Silicone-covered biodegradable magnesium-stent insertion in the esophagus: a comparison with plastic stents
|
Zhu, Yue-Qi
|
|
2017
|
|
1 |
p. 11-19
|
artikel
|
| 51 |
Split dose and MiraLAX-based purgatives to enhance bowel preparation quality becoming common recommendations in the US
|
Hillyer, Grace Clarke
|
|
2013
|
|
1 |
p. 5-14
|
artikel
|
| 52 |
Steroids and 5-aminosalicylic acids in moderate ulcerative colitis: addressing the dilemma
|
Probert, Chris
|
|
2013
|
|
1 |
p. 33-38
|
artikel
|
| 53 |
Structured management strategy versus usual care for gastroesophageal reflux disease: rationale for pooled analysis of five European cluster-randomized trials
|
Ponce, Julio
|
|
2011
|
|
1 |
p. 11-26
|
artikel
|
| 54 |
Successful use of volumetric laser endomicroscopy in imaging a rectal polyp
|
Trindade, Arvind J.
|
|
2016
|
|
1 |
p. 128-131
|
artikel
|
| 55 |
Surveillance for hepatocellular carcinoma: in whom and how?
|
El-Serag, Hashem B.
|
|
2011
|
|
1 |
p. 5-10
|
artikel
|
| 56 |
Systematic review and meta-analysis: the effects of fermented milk with Bifidobacterium lactis CNCM I-2494 and lactic acid bacteria on gastrointestinal discomfort in the general adult population
|
Eales, Jacqui
|
|
2017
|
|
1 |
p. 74-88
|
artikel
|
| 57 |
Targeting histone methylation for colorectal cancer
|
Huang, Tao
|
|
2017
|
|
1 |
p. 114-131
|
artikel
|
| 58 |
Targeting ion channels for the treatment of gastrointestinal motility disorders
|
Beyder, Arthur
|
|
2012
|
|
1 |
p. 5-21
|
artikel
|
| 59 |
The emerging role of miRNAs in inflammatory bowel disease: a review
|
Chapman, Christopher G.
|
|
2015
|
|
1 |
p. 4-22
|
artikel
|
| 60 |
The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease?
|
Bien, Justyna
|
|
2013
|
|
1 |
p. 53-68
|
artikel
|
| 61 |
The potential utility of tight junction regulation in celiac disease: focus on larazotide acetate
|
Khaleghi, Shahryar
|
|
2016
|
|
1 |
p. 37-49
|
artikel
|
| 62 |
Therapeutic management options for patients with obscure gastrointestinal bleeding
|
Kochhar, Gursimran S.
|
|
2012
|
|
1 |
p. 71-81
|
artikel
|
| 63 |
The role and utility of faecal markers in inflammatory bowel disease
|
Lehmann, Frank S.
|
|
2015
|
|
1 |
p. 23-36
|
artikel
|
| 64 |
The role of ferric carboxymaltose in the treatment of iron deficiency anemia in patients with gastrointestinal disease
|
Koduru, Pramoda
|
|
2016
|
|
1 |
p. 76-85
|
artikel
|
| 65 |
The role of obesity in gastrointestinal cancer: evidence and opinion
|
Donohoe, Claire L.
|
|
2014
|
|
1 |
p. 38-50
|
artikel
|
| 66 |
Treatment of resectable gastric cancer
|
Dikken, Johan L.
|
|
2012
|
|
1 |
p. 49-69
|
artikel
|
| 67 |
Trend towards dose reduction of azathioprine as monotherapy in inflammatory bowel disease patients: what about for combination therapy?
|
Williet, Nicolas
|
|
2017
|
|
1 |
p. 5-10
|
artikel
|
| 68 |
Ustekinumab for the treatment of Crohn’s disease: can it find its niche?
|
Simon, Ebby G.
|
|
2016
|
|
1 |
p. 26-36
|
artikel
|
Tijdschrift beschrijving